Exact Sciences (EXAS) said Sunday it expects to report Q4 revenue of $713 million, up 10% from a year earlier.
Analysts polled by FactSet are expecting $696.9 million.
For full-year 2024, the company expects revenue to increase by 10% to $2.76 billion.
Analysts polled by FactSet are expecting $2.74 billion.
The company plans to report earnings in February.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。